Is Relmada Therapeutics, Inc. (RLMD) a Buy, Sell, or Hold?
NASDAQ : RLMD
Relmada Therapeutics, Inc.
$5.46 USD
-$0.75 (-12.08%)
- Volume
- 1.87M
- Average Volume
- 1.61M
- Market Capitalization
- $572.7M
- P/E Ratio
- -4.92
- Dividend Yield
- 0.00%
- Price Target
- $10.00
- Year High
- $8.00
- Year Low
- $0.55
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $18.26
RLMD vs. The Competition
| Properties | RLMD | ACET | ACRV | CBUS |
|---|---|---|---|---|
| Market Cap | $572.7M | $79.46M | $55.22M | $84.15M |
| Shares Outstanding | $104.89M | $9.35M | $31.56M | $45.49M |
| P/E Ratio | -4.92 | -0.57 | -0.88 | -1.05 |
| EPS | -0.68 | -10.13 | -2.0 | -0.16 |
| Day Low | 5.4301 | 8.4165 | 1.735 | 1.845 |
| Day high | 6.26 | 8.67 | 1.89 | 2.07 |
| Year Low | 0.55 | 6.01 | 1.2 | 1.09 |
| Year High | 8 | 17.44 | 3.56 | 4.191 |
| Average Price 50 | 6.7628 | 8.245 | 1.7308 | 1.4607 |
| Average Price 200 | 5.02795 | 8.90352 | 1.87655 | 1.8155 |
| Volume | 1.87M | 23685.84 | 536.68K | 309.14K |
| Average Volume | - | - | - | - |